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Abstract
Background: Children diagnosed with cancer often require extensive care for medical, psychosocial and
educational problems during and after therapy. Part of this care is provided by family physicians and non-cancer
specialists, but their involvement in the first years after diagnosis has barely been studied. Studying non-oncology
physician visits may provide insight into the roles of different health care providers.
Methods: We included 757 children diagnosed with cancer under age 15 between 1991 and 2001 from a
Canadian provincial registry, and matched each to 10 controls of the same birth year and sex. We determined the
number of family physician and non-cancer specialist visits in the 5 years after diagnosis (for patients) or inclusion
(for controls) using data from the provincial health insurance plan.
Results: In the first year after diagnosis, almost all patients visited both a family physician and non-cancer
specialist. Although after 5 years percentages decreased to 85 and 76 %, respectively, these were still significantly
higher than in controls. In the first year after diagnosis, both family physicians and non-cancer specialists were
often consulted for neoplasms (62 and 90 %, respectively) and to discuss results of lab tests. In addition, family
physicians were often consulted for general symptoms and non-cancer specialists for nervous system problems
and complications of medical care.
Conclusions: Family physicians and non-cancer specialists are highly involved in the care for children with
cancer in the first years after diagnosis, including for health problems related to cancer or its treatment. This
necessitates good communication among all physicians.
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Background
Survival rates of children diagnosed with cancer have im-
proved greatly in the last 50 years, from 30 % surviving
more than 5 years in the 1960s up to more than 80 % cur-
rently [1, 2]. As more and more children survive, it is also
increasingly being realized that survival comes at a price;
children who survive cancer often experience long-term
health problems, related to the cancer itself or its treat-
ment [3, 4]. Common problems are neurocognitive dys-
function, cardiovascular diseases, infertility or gonadal
dysfunction, and psychosocial problems [5].
Especially in the first years after diagnosis, children
require extensive care for medical, psychosocial and edu-
cational problems. Many health care providers may be
involved in this care. Treatment for childhood cancer is
relatively lengthy and patients are often closely moni-
tored by a cancer specialist for several years after the
diagnosis, but they may also visit a non-cancer spe-
cialist or a family physician for the more general
health effects they experience because of the cancer
and its treatment, such as problems with growth and
development and learning [6].
In many countries, the family physician has an import-
ant role in the long-term care for cancer survivors. The
generalist and patient-focused view of the family phys-
ician facilitates addressing the variety of issues that these
patients encounter. The role of the family physician has
mostly been studied among adult cancer patients and
several studies showed that up to 10 years after diagnosis
they visit their family physician more often than non-
cancer controls of the same age [7, 8]. Increased family
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physician visits are also seen in adult survivors of child-
hood cancer [9–11].
Non-oncology physician visits in the first few years
after diagnosis of cancer in children have barely been
studied. We therefore do not know which roles the non-
cancer specialist and family physician play in the care
for these children during this period; how often are they
visited and for which health problems. If family physi-
cians and non-cancer specialists are also involved in care
for cancer-related problems, this may benefit continuity
of care towards long-term follow-up but it also necessi-
tates good communication between all health providers
involved.
Using the linked provincial registry, clinical, and ad-
ministrative datasets of the Childhood, Adolescent, and
Young Adult Cancer Survivor (CAYACS) Research Pro-
gram, [12] we aimed to compare non-oncology physician
visits in the first 5 years after diagnosis of childhood
cancer to that of non-cancer controls of the same age
and sex. We looked at both the number of visits and the
reasons for these visits.
Methods
Study population
Patients were selected from the British Columbia (BC)
cancer registry. Inclusion criteria were diagnosis with a
primary cancer before 15 years of age in the period 1991
until 2001, residence in the province of BC at time of
diagnosis and successful linkage to registration files from
the provincial health insurance plan based on a unique
Personal Health Number. For each patient ten control
children of the same birth year and sex were selected
from the provincial health insurance plan registry.
Data collection
Data on non-oncology physician visits of both patients
and controls were retrieved from the provincial health
insurance plan, containing records of all medically-
necessary physician-ordered outpatient services of resi-
dents of BC since 1986 (British Columbia Ministry of
Health [Mc Bride] (2013): Medical Services Plan (MSP)
Payment Information File. Population Data BC BC Can-
cer Agency. Data Extract. MOH (2012). http://www.pop-
data.bc.ca/data). Diagnoses were coded using the ICD
(International Classification of Diseases) [13]. Available
data on family physician and specialist visits and diagno-
ses made during these visits were extracted from diagno-
sis (for patients) or inclusion (for controls; individually
matched to case diagnosis date) up to 5 years after this
date. Data were right-censored if children died or they
moved out of BC. Clinical data of patients (i.e. diagnosis,
treatment, relapse status) was available as part of the
CAYACS Program [12] Residence of both patients and
controls, recorded as annual postal code, was retrieved
from the provincial health insurance plan (BC Vital Sta-
tistics Agency [McBride] (2012): Vital Statistics Deaths.
Population Data BC BC Cancer Agency. Data Extract
BC Vital Statistics Agency (2012). http://www.popda-
ta.bc.ca/data), and used to link to census data to generate
area-specific socioeconomic status, region (i.e. regional
health administration area) and urban or rural.
Analysis
First, we compared the percentage with a family phys-
ician and non-cancer specialist visit in cancer patients
and controls in each year using a X2 test. We then calcu-
lated the mean number of family physician and non-
cancer specialist visits in those cancer patients and con-
trols with a visit. We then used multiple negative bino-
mial regression analyses to test whether the difference
between both groups was statistically significant [14].
We chose this type of regression analysis since our out-
come variable, the number of visits, is a count variable
and follows a so-called negative-binomial distribution.
We tested for overdispersion in the data, which was
indeed present. Negative binomial regression is espe-
cially suited for this type of distribution. For each
year after diagnosis or inclusion we built a model
with the number of visits as dependent, and patient/
control status as independent variable.
Next, we examined the reasons that had been recorded
for each visit, by calculating the percentage of patients
and controls with a visit by ICD chapter. Finally, we cal-
culated the percentage of patients and controls with a
visit by specialty.
Analyses were performed using IBM® SPSS® version
21. A p-value below 0.05 was considered statistically
significant.
Results
The BC Cancer Registry identified 757 children under
15 years of age diagnosed with cancer between January
1991 and December 2001. They were matched to 7441
controls of the same birth year and sex. Half of the pa-
tients were under 4 years of age, and 56 % were males.
Patients and controls did not differ significantly on any
baseline characteristics (See Table 1). Clinical character-
istics of the cancer patients are presented in Table 2.
Most frequent cancer types were leukemia and central
nervous system tumours and 71 % of the patients had
been treated with chemotherapy.
In the first year after diagnosis almost all cancer pa-
tients visited a family physician (97 %) and non-cancer
specialist (98 %, see Table 3). This was significantly more
than the controls, of whom 83 % visited a family phys-
ician and only 29 % a non-cancer specialist. In the years
thereafter, the proportion of cancer patients with a visit
declined steadily to 85 % for family physician and to
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Table 1 Socio-demographic characteristics of patients and controls
Patients (N = 757) Controls (N = 7441) p
n % n %
Sex Male 421 56 4096 55 .77
Female 336 44 3345 45
Age at diagnosis/inclusion 0-4 358 47 3521 47 1.00
5–9 196 26 1935 26
10–14 203 27 1985 27
Socioeconomic Status Quintile (SES) 5 (highest) 142 20 1306 18 .31
4 139 18 1401 19
3 162 21 1409 19
2 143 19 1462 20
1 (lowest) 129 17 1432 20
Unknown 42 6 345 18
Urban/rural Status Metropolitan 400 52 4104 56 .37
Large Community 82 11 747 10
Small Community 148 20 1283 18
Rural 126 17 1199 16
Unknown 0 0 1 0
Region of Residence Interior 127 17 1184 16 .86
Frasier 244 32 2469 34
Vancouver Coastal 166 22 1645 22
Vancouver Island 123 16 1219 17
Northern 81 11 692 9
Unknown 16 2 146 2
Table 2 Clinical characteristics of patients (N = 757)
Number Percent
Calendar period of diagnosis 1991–1995 410 54
1996–2000 347 46
Diagnosis Leukemia 263 35
Central Nervous System 153 20
Lymphoma 78 10
Soft tissue sarcoma 46 6
Bone 33 4
Germ Cell 32 4
Carcinoma 24 3
Other 128 17
Treatment Modality Surgery only 165 22
Chemotherapy (Chemo) 402 53
Radiation (RT) 22 3
Chemo and RT 136 18
Other/Unknown 32 4
Relapse status at end follow-up Cancer free 678 90
Relapse/secondary cancer 79 10
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76 % for non-cancer specialist visits, which was still sig-
nificantly more than the controls. If children had a visit,
the number of visits was also higher in cancer patients,
with a mean of 10 family physician and 20 non-cancer
specialist visits in the first year after diagnosis, com-
pared to 2 and 5 in controls, respectively. The num-
ber of visits in cancer patients dropped to about 5
family physician and 5 non-cancer specialist visits in
the fifth year after diagnosis, which was still signifi-
cantly higher than the controls.
In the first year ‘neoplasms’ and ‘signs and symptoms’
were the most common reason for cancer patients to
visit a family physician (See Fig. 1). ‘Signs & symptoms’
were for a large part ‘general symptoms’ (31 %), or were
related to the head and neck (11 %) or skin (10 %) (See
Table 4). In the fifth year after diagnosis, visits for neo-
plasms had decreased, but ‘signs & symptoms’ remained
the most frequent reason for visit and were still signifi-
cantly more frequent than in the controls (50 % versus
44 %, p < 0.001). Another common reason for a family
physician visit for cancer patients were respiratory prob-
lems, mainly acute respiratory infections, although these
were even more common in controls in the first year
after diagnosis (41 % versus 48 %, p = 0.001). Other com-
mon reasons for visit were neurological problems,
mainly otitis media (52 % of neurological problems), and
‘additional codes’, mostly visits to discuss results of
laboratory tests (74 % of additional codes).
As to non-cancer specialist visits, the most common
reasons for visit were ‘neoplasms’ and ‘additional codes’,
the latter mainly related to discussing results of labora-
tory tests (83 % of additional codes) and ear tests (13 %)
(See Table 5). Although both decreased, they were still
the most common reasons for visit in the fifth year after
diagnosis (See Fig. 2). Another common reason for visit
were ‘signs and symptoms’, related to a variety of health
problems, such as ‘general symptoms’ (19 %), respiratory
problems (15 %), or fever of unknown origin (10 %).
Visits related to the nervous system most frequently
concerned disorders of the brain (12 %) and otitis media
(15 %). Finally, visits for ‘Injury and poisoning’ were
common in the first year after diagnosis, largely related
to complications of medical care (56 %). Among con-
trols, non-cancer specialist visits were significantly less
Table 3 Proportion of patients and controls with at least one physician visit, and mean (SD) number of visits of those with a visit by
time since diagnosis
Visits Yr. 1 Yr2 Yr3 Yr4 Yr5 p-trend
N % No. Visits N % No. Visits N % No. Visits N % No. Visits N % No. Visits
All visits Patients 756 100a 29.9 (18.5)a 735 98a 15.0 (13.9)a 722 97a 12.1 (10.9)a 709 96a 9.7 (8.9)a 692 94a 8.4 (8.0)a <.001
Controls 6290 85 5.8 (5.4) 6182 84 5.3 (4.7) 5982 82 5.0 (4.5) 5889 81 4.9 (4.8) 5763 80 4.7 (4.8) <.001
Family
physician
Patients 737 97a 10.1 (9.9)a 683 91a 7.7 (9.2)a 671 90a 6.8 (7.2)a 668 91a 5.4 (4.8)a 624 85a 5.0 (4.5)a <.001
Controls 6143 83 5.0 (4.4) 6029 82 4.5 (3.8) 5824 79 4.2 (3.6) 5712 79 4.2 (3.9) 1720 78 4.0 (3.7) <.001
Non-cancer Patients 739 98a 20.4 (16.2)a 658 88a 8.7 (10.8)a 619 83a 6.7 (8.1)a 578 78a 5.6 (7.5)a 557 76a 4.8 (6.2)a <.001
specialist Controls 2158 29 2.8 (3.4) 2051 28 2.7 (3.1) 2014 28 2.7 (2.8) 1918 26 2.7 (3.1) 1866 26 2.7 (3.8) <.001
No. visits is the mean number (standard deviation) of visits of those who had at least one visit
aAll comparisons between patients and controls are statistically significant (p < 0.001)
Fig. 1 Proportion of patients with a family physician visit, by reason for visit (5 most frequent)
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Table 4 Most frequent ICD codes by chapter for patients’ family physician visits
Chapter ICD code Number Percent
Signs & symptoms General symptoms 1667 31.2
Symptoms involving head and neck 601 11.2
Symptoms involving skin and other integumentary tissue 578 10.8
Symptoms involving respiratory system 493 9.2
Symptoms involving nervous and musculoskeletal systems 465 8.7
Respiratory system Acute upper respiratory infections of multiple or unspecified site 1095 26.5
Acute nasopharyngitis (common cold) 769 18.6
Acute pharyngitis 429 10.4
Acute bronchitis and bronchiolitis 379 9.2
Acute tonsillitis 273 6.6
Additional codes Laboratory 4925 73.7
X-Ray 439 6.6
Abdominal pain 165 2.5
Injection – Other 150 2.2
Plantar warts 145 2.2
Nervous system Suppurative and unspecified otitis media 899 43.5
Disorders of the conjunctiva 182 8.8
Nonsuppurative otitis media and eustachian tube disorders 169 8.2
Disorders of external ear 131 6.3
Other disorders of ear 128 6.2
Table 5 Most frequent ICD codes by chapter for patients’ non-cancer specialist visits
Chapter ICD code Number Percent
Signs & symptoms General symptoms 510 19.0
Symptoms involving respiratory system 394 14.7
Pyrexia of unknown origin 274 10.2
Other nonspecific abnormal findings 173 6.4
Symptoms involving nervous and musculoskeletal systems 147 5.5
Additional codes Laboratory 12843 82.8
Ear tests 1961 12.6
X-Ray 268 1.7
Eye tests 131 .8
Abdominal pain 127 .8
Nervous system Other conditions of brain 383 12.2
Nonsuppurative otitis media and eustachian tube disorders 286 9.1
Strabismus and other disorders of binocular eye movements 286 9.1
Epilepsy 246 7.8
Suppurative and unspecified otitis media 179 5.7
Injuries & poisoning Other complications of procedures, not elsewhere classified 437 38.5
Complications peculiar to certain specified procedures 107 9.4
Complications of medical care, not elsewhere classified 96 8.5
Fracture of radius and ulna 44 3.9
Fracture of tibia and fibula 40 3.5
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common; percentages of controls having a visit in any
year did not exceed 8 %.
Paediatrics was the most frequently visited specialty
provider, among both patients and controls. Eighty-
seven percent of the patients had a visit with a paediatri-
cian in the first year after diagnosis, decreasing to 46 %
in the fifth year. This was significantly higher than the
13 % among controls. Especially in the first year after
diagnosis, visits to general surgery and paediatric cardi-
ology were also common (63 % and 52 %, respectively).
Less than 1 % of the controls paid a visit to these two
specialty medical providers.
Discussion
Results of this study show that children with cancer are
seen very frequently by family physicians and non-
cancer specialists in the first years after diagnosis. The
number of visits decreases gradually over the first 5
years, but remains higher than that of their peers with-
out cancer. Both family physicians and non-cancer spe-
cialists were often consulted for neoplasm-related health
problems and discussion of results of lab tests. In
addition, family physicians were often consulted for gen-
eral symptoms, while non-cancer specialists were more
often consulted for problems to the nervous system and
complications of medical care. So both family physicians
and non-cancer specialists seem to be extensively
involved in the care for children with cancer during this
phase of care.
Physician visits in the first years after diagnosis of
cancer in children have not been extensively studied.
Some studies did examine physician visits after this
period. Shaw et al., who surveyed physician visits in
Canadian survivors of child and adolescent cancer
more than 5 years after diagnosis, reported that 71
and 68 % of survivors visited a family physician or a
specialist in a 1-year period [11]. This is lower than
the 85 and 76 % we found in the fifth year after diag-
nosis. The CAYACS Program, using administrative
health records, reported that 97 % of an earlier co-
hort of BC childhood cancer survivors surviving more
than 5 years after diagnosis saw a physician (other
than an oncologist) in an outpatient setting in a 3-
year period [9]. The Childhood Cancer Survivor
Study, surveying a cohort of survivors of child and
adolescent cancer patients residing mainly in the US,
found that 88 % of 18–19 year olds reported a gen-
eral medical contact in a two year period, more than
5 years after diagnosis [10]. However, these percent-
ages cannot be compared to those found in this
paper, as their time after diagnosis was much longer
and some of them did not calculate annual but two
or three yearly contact rates.
For this study we used clinical data from a large co-
hort of geographically-identified children with cancer
linked to provincial health claims data. This enabled
us to study physician visits of a large representative
group of children over several years without the
potential for biases associated with incomplete ascer-
tainment and self-report, such as recall bias and self-
selection. Moreover, these claims data most likely give
a complete picture of the non-oncology physician
visits of these children, given that all medically neces-
sary care is provided only through the provincial
government. Our data were restricted to the province
of British Columbia, so some patients were lost to
follow-up as they moved out of BC; but this number
is small and is unlikely to significantly alter the
results [12].
Physicians could only record one ICD code per
visit, although patients may have presented more than
one health problem. We may therefore have missed
some health problems, but physicians will likely have
chosen the most important one. Unfortunately, in a
Fig. 2 Proportion of patients with a non-cancer specialist visit, by reason for visit (5 most frequent)
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relatively high percentage of family physician visits
the related ICD code was ‘general symptoms’ (17 %),
which is not very informative. Although there may
have been errors or lack of specificity in the diagnos-
tic codes, it is not likely that coding errors will be
different between patients and controls or between
family physicians and specialists. The percentage of
visit records with a missing ICD code was low
(0.2 %), which indicates good data quality.
In our data, we could not make a distinction between
community paediatricians and specialist paediatricians
and considered both as specialist paediatricians. Com-
munity paediatricians often serve as primary care pro-
viders of children, but they have extensive training in
paediatric medicine, so they could be considered some-
where between a family physician and a specialist
paediatrician.
Conclusions
We found that children with cancer visited both their
family physician and paediatrician very often in the first
5 years after diagnosis, also for cancer-related health
problems. Although visits to both disciplines decreased
somewhat over time, they are considerably more fre-
quent than among controls during the 5-year period.
The involvement of family physicians and non-cancer
specialists in the care for children with cancer stresses
the importance of good communication between all phy-
sicians involved in addressing health problems and treat-
ment of the child.
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